US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Terminated

Neostigmine Methylsulfate

Reason Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.

Premier Pharmacy Labs Inc D-1422-2019
Class II · Moderate risk Terminated

Naloxone HCL Preserved INJ

Reason Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.

Premier Pharmacy Labs Inc D-1421-2019
Class II · Moderate risk Terminated

Mitomycin Preservative Free Irrigation

Reason Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.

Premier Pharmacy Labs Inc D-1420-2019
Class II · Moderate risk Terminated

Lidocaine 0.5%/Phenylephrine 0.75% P.F. INJ

Reason Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.

Premier Pharmacy Labs Inc D-1419-2019
Class II · Moderate risk Terminated

Isoproterenol HCL in D5W

Reason Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.

Premier Pharmacy Labs Inc D-1418-2019
Class II · Moderate risk Terminated

Isoproterenol HCL in D5W

Reason Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.

Premier Pharmacy Labs Inc D-1417-2019
Class II · Moderate risk Terminated

Isoproterenol HCL in D5W

Reason Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.

Premier Pharmacy Labs Inc D-1416-2019
Class II · Moderate risk Terminated

Droperidol Injectable Sterile Solution

Reason Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.

Premier Pharmacy Labs Inc D-1415-2019
Class II · Moderate risk Terminated

Dexamethasone Sodium Phosphate Preservative Free Sterile Solution for INJ

Reason Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.

Premier Pharmacy Labs Inc D-1414-2019
Class II · Moderate risk Terminated

ChlorproMAZINE HCL INJ

Reason Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.

Premier Pharmacy Labs Inc D-1413-2019
Class II · Moderate risk Terminated

Brilliant Blue Ophthalmic PF INJ

Reason Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.

Premier Pharmacy Labs Inc D-1412-2019
Class II · Moderate risk Terminated

Atropine Sulfate PF INJ

Reason Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.

Premier Pharmacy Labs Inc D-1411-2019
Class II · Moderate risk Terminated

Losartan Potassium

Reason CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.

Golden State Medical Supply Inc. NDC 60429-318-90 D-1465-2019
Class II · Moderate risk Terminated

Losartan Potassium

Reason CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.

Golden State Medical Supply Inc. NDC 60429-317-10 D-1464-2019
Class II · Moderate risk Terminated

Losartan Potassium

Reason CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.

Golden State Medical Supply Inc. NDC 60429-317-90 D-1463-2019
Class II · Moderate risk Terminated

Losartan Potassium

Reason CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.

Golden State Medical Supply Inc. NDC 60429-317-30 D-1462-2019
Class II · Moderate risk Terminated

Sevoflurane

Reason Failed Stability Specifications

Baxter Healthcare Corporation NDC 10019-651-64 D-1435-2019
Class II · Moderate risk Terminated

Heparin Sodium 25

Reason Subpotent Drug: low out-of-specification results were identified for the drug anti-factor IIa potency which is intended to ensure that the potency of heparin is within the USP specifications.

B. Braun Medical Inc NDC 0264-9587-20 D-1343-2019
Class II · Moderate risk Terminated

Vincristine 1 Mg /50 Ml Ns Ivpb

Reason Lack of Assurance of Sterility

Infusion Options, Inc. D-1818-2019